Evaluation of physicochemical properties and intestinal permeability of six dietary polyphenols in human intestinal colon adenocarcinoma Caco-2 cells

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 41, Issue 1, 2016, Pages 33-43

  Rastogi, Himanshu ^a   Jana, Snehasis ^b  

^a SURESH GYAN VIHAR UNIVERSITY   (India)

^b Laila Research Centre   (India)

Author keywords

Caco 2; Parallel artificial membrane permeability; Partition coefficient; Polyphenols

Indexed keywords

CAFFEIC ACID; CHRYSIN; GALLIC ACID; QUERCETIN; RESVERATROL; RUTOSIDE; POLYPHENOL;

ARTICLE; CACO 2 CELL LINE; CHEMICAL STRUCTURE; COLON ADENOCARCINOMA; DIET SUPPLEMENTATION; DIFFUSION; DISSOCIATION CONSTANT; FUNCTIONAL FOOD; INTESTINE MUCOSA PERMEABILITY; LIPOPHILICITY; MEMBRANE PERMEABILITY; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; THERMODYNAMICS; ADENOCARCINOMA; CACO-2 CELL LINE; CHEMICAL PHENOMENA; CHEMISTRY; COLON TUMOR; DRUG EFFECTS; HUMAN; INTESTINE; INTESTINE ABSORPTION; INTESTINE MUCOSA; METABOLISM; PERMEABILITY; PHYSIOLOGY;

ADENOCARCINOMA; CACO-2 CELLS; CHEMICAL PHENOMENA; COLONIC NEOPLASMS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTESTINES; PERMEABILITY; POLYPHENOLS;

EID: 84956682190     PISSN: 03787966     EISSN: 21070180     Source Type: Journal    
DOI: 10.1007/s13318-014-0234-5     Document Type: Article

References (30)

1. Fichert T, Yazdanian M, Proudfoot JR (2003) A structure-permeability study of small drug-like molecules. Bioorg Med Chem Lett 13:719-722
2. Fresco P, Borges F, Diniz C, Marques MP (2006) New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26:747-766
3. Han X, Shen T, Lou H (2007) Dietary polyphenols and their biological significance. Int J Mol Sci 8:950-988
4. Hilgers AR, Conradi RA, Burton PS (1990) Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res 7:902-910
5. Hollman PCH, Katan MB (1997) Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother 51:305-310
6. Justesen U, Knuthsen P, Leth T (1998) Quantitative analysis of flavonols, flavones, and flavanones in fruits, vegetables and beverages by high-performance liquid chromatography with photo-diode array and mass spectrometric detection. J Chromatogr A 799:101-110
7. Kansy M, Senner F, Gubernator K (1998) Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 26:1007-1010
8. Kerns EH, Di L, Petusky S, Farris M, Ley R, Jupp P (2004) Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. J Pharm Sci 93:1440-1453
9. Kobayashi S, Nagai T, Konishi Y, Tanabe S, Morimoto K (2012) Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes. J Pharm Pharmacol 64:52-60
10. Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C, Williamson G (2004) How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 80:15-21
11. Lajiness M, Vieth M, Erickson J (2004) Molecular properties that influence oral drug-like behavior. Curr Opin Drug Discov Devel 7:470-477
12. Link A, Balaguer F, Goel A (2010) Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 80:1771-1792
13. Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1:337-341
14. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3-26
15. Liu X, Testa B, Fahr A (2011) Lipophilicity and its relationship with passive drug permeation. Pharm Res 28:962-977
16. Lotito SB, Frei B (2006) Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 41:1727-1746
17. Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230S-242S
18. Neuhoff S, Ungell AL, Zamora I, Artursson P (2005) pH-dependent passive and active transport of acidic drugs across Caco-2 cell monolayers. Eur J Pharm Sci 25:211-220
19. Prasain JK, Barnes S (2007) Metabolism and bioavailability of flavonoids in chemoprevention: current analytical strategies and future prospectus. Mol Pharm 4:846-864
20. Rahman I, Biswas SK, Kirkham PA (2006) Regulation of inflammation and redox signalling by dietary polyphenols. Biochem Pharmacol 72:1439-1452
21. Refsgaard HHF, Jensen B, Brockhoff P, Padkjr S, Guldbrandt M, Christensen M (2005) In silico prediction of membrane permeability from calculated molecular parameters. J Med Chem 48:805-811
22. Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S-2085S
23. Schieber A, Keller P, Carle R (2001) Determination of phenolic acids and flavonoids of apple and pear by high-performance liquid chromatography. J Chromatogr A 910:265-273
24. Silberberg M, Morand C, Mathevon T, Besson C, Manach C, Scalbert A, Remesy C (2006) The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites. Eur J Nutr 45:88-96
25. Suzuki H, Sugiyama Y (2000) Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur J Pharm Sci 12:3-12
26. Tian XJ, Yang XW, Yang X, Wang K (2009) Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model. Int J Pharm 367:58-64
27. van de Waterbeemd H, Gifford E (2003) ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2:192-204
28. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability or drugs. J Med Chem 45:2615-2623
29. Vieth M, Siegel MG, Higgs RE, Watson IA, Robertson DA, Savin KA, Durst GL, Hipskind PA (2004) Characteristic physical properties and structural fragments of marketed drugs. J Med Chem 47:224-232
30. Wenlock MC, Austin RP, Barton P, Davis AM, Leeson PD (2003) A comparison of physicochemical property profiles of development and marketed oral drugs. J Med Chem 46:1250-1256